Cerecor Inc (CERC) Director Buys $23,739.60 in Stock

Cerecor Inc (NASDAQ:CERC) Director Armistice Capital, Llc bought 6,504 shares of the business’s stock in a transaction that occurred on Monday, January 7th. The shares were acquired at an average cost of $3.65 per share, with a total value of $23,739.60. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

Armistice Capital, Llc also recently made the following trade(s):

  • On Friday, January 4th, Armistice Capital, Llc bought 20,000 shares of Cerecor stock. The shares were acquired at an average cost of $3.42 per share, with a total value of $68,400.00.
  • On Tuesday, December 31st, Armistice Capital, Llc bought 12,300 shares of Cerecor stock. The shares were acquired at an average cost of $3.18 per share, with a total value of $39,114.00.
  • On Saturday, December 28th, Armistice Capital, Llc purchased 26,499 shares of Cerecor stock. The shares were purchased at an average price of $3.12 per share, for a total transaction of $82,676.88.
  • On Monday, December 31st, Armistice Capital, Llc purchased 12,300 shares of Cerecor stock. The shares were purchased at an average price of $3.18 per share, for a total transaction of $39,114.00.
  • On Friday, December 28th, Armistice Capital, Llc purchased 26,499 shares of Cerecor stock. The shares were purchased at an average price of $3.12 per share, for a total transaction of $82,676.88.
  • On Monday, December 17th, Armistice Capital, Llc purchased 14,938 shares of Cerecor stock. The shares were purchased at an average price of $3.26 per share, for a total transaction of $48,697.88.
  • On Friday, December 14th, Armistice Capital, Llc purchased 28,032 shares of Cerecor stock. The shares were purchased at an average price of $3.33 per share, for a total transaction of $93,346.56.
  • On Monday, December 10th, Armistice Capital, Llc purchased 13,815 shares of Cerecor stock. The shares were purchased at an average price of $3.36 per share, for a total transaction of $46,418.40.
  • On Thursday, December 6th, Armistice Capital, Llc purchased 16,400 shares of Cerecor stock. The shares were purchased at an average price of $3.44 per share, for a total transaction of $56,416.00.
  • On Monday, December 3rd, Armistice Capital, Llc purchased 19,495 shares of Cerecor stock. The shares were purchased at an average price of $3.50 per share, for a total transaction of $68,232.50.

Cerecor stock opened at $3.89 on Friday. The company has a market capitalization of $154.25 million, a price-to-earnings ratio of 9.26 and a beta of 1.30. The company has a current ratio of 0.74, a quick ratio of 0.70 and a debt-to-equity ratio of 0.74. Cerecor Inc has a twelve month low of $2.18 and a twelve month high of $5.74.

Cerecor (NASDAQ:CERC) last released its quarterly earnings data on Tuesday, November 13th. The company reported ($0.26) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.12) by ($0.14). The company had revenue of $4.08 million during the quarter, compared to analyst estimates of $4.80 million. Cerecor had a negative net margin of 241.29% and a negative return on equity of 75.94%. Equities research analysts forecast that Cerecor Inc will post -1.09 earnings per share for the current year.

A number of research firms have recently issued reports on CERC. LADENBURG THALM/SH SH began coverage on shares of Cerecor in a report on Thursday, December 20th. They set a “buy” rating and a $9.00 price target on the stock. TheStreet lowered shares of Cerecor from a “c” rating to a “d” rating in a report on Monday, December 17th. Finally, ValuEngine upgraded shares of Cerecor from a “hold” rating to a “buy” rating in a report on Thursday, November 1st.

Institutional investors have recently added to or reduced their stakes in the business. Vanguard Group Inc boosted its holdings in shares of Cerecor by 10.1% during the 3rd quarter. Vanguard Group Inc now owns 87,929 shares of the company’s stock worth $411,000 after buying an additional 8,094 shares during the period. Cambridge Investment Research Advisors Inc. bought a new stake in shares of Cerecor during the 3rd quarter worth $169,000. Finally, BlackRock Inc. boosted its holdings in shares of Cerecor by 630.4% during the 2nd quarter. BlackRock Inc. now owns 27,520 shares of the company’s stock worth $120,000 after buying an additional 23,752 shares during the period. Hedge funds and other institutional investors own 44.48% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “Cerecor Inc (CERC) Director Buys $23,739.60 in Stock” was first posted by Markets Daily and is owned by of Markets Daily. If you are reading this story on another site, it was copied illegally and reposted in violation of U.S. & international trademark and copyright law. The original version of this story can be viewed at https://www.themarketsdaily.com/2019/01/11/cerecor-inc-cerc-director-buys-23739-60-in-stock.html.

About Cerecor

Cerecor Inc, a pharmaceutical company, focuses on pediatric health care. Its lead product portfolio includes prescribed dietary supplements, such as Poly-Vi-Flor and Tri-Vi-Flor; and prescription drugs, such as Millipre, Veripred, and Ulesfia for the treatment of inflammation of the skin, joints, lungs, and other organs, as well as asthma, allergies, arthritis, and head lice infestation.

Further Reading: Net Asset Value

Insider Buying and Selling by Quarter for Cerecor (NASDAQ:CERC)

Receive News & Ratings for Cerecor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerecor and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply